MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, KZR made $12,741K in revenue. -$11,227K in net income. Net profit margin of -88.12%.

Income Overview

Revenue
$12,741K
Net Income
-$11,227K
Net Profit Margin
-88.12%
EPS
-$1.53
Unit: Thousand (K) dollars
Revenue Breakdown
    • Research and development
    • General and administrative
    • Interest income

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2025-06-30
2024-12-31
2024-09-30
Research and development
6,914 9,583 16,500 16,242
General and administrative
4,801 5,016 5,896 5,706
Restructuring and impairment charges
0 0 368 -
Total operating expenses
11,715 14,599 22,886 21,948
Loss from operations
-11,715 -14,599 -22,886 -21,948
Interest income
1,026 1,197 2,116 2,038
Interest expense
-302 398 403
Other expenses
538 ---
Net loss
-11,227 -13,704 -21,141 -20,313
Net loss per common share, basic (in dollars per share)
-1.53 -1.87 -2.903 -2.78
Net loss per common share, diluted (in dollars per share)
-1.53 -1.87 -2.903 -2.78
Weighted-average shares used to compute net loss per common share, basic (in shares)
7,323,106 7,311,032 -1,992.333 7,296,222
Weighted-average shares used to compute net loss per common share, diluted (in shares)
7,323,106 7,311,032 -1,992.333 7,296,222
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$11,227K Interest income$1,026K Other expenses$538K Loss from operations-$11,715K Total operatingexpenses$11,715K General andadministrative$4,801K Research and development$6,914K

Kezar Life Sciences, Inc. (KZR)

Kezar Life Sciences, Inc. (KZR)